Navigation Links
TB Vaccines: Ring Out the New, Bring in the Old

Old may be gold, according to the journal Proceedings of the National Academy of Sciences. The report states that the present TB vaccines are losing their efficiency in// preventing tuberculosis, and scientists may do well to resurrect older versions of the vaccine.

The scientists led by Dr. Roland Brosch of the Institut Pasteur opine that modern BCG or bacillus Calmette Guerin vaccines used in immunization of 2 million children around the world weekly, are losing their power, probably due to changes in the genetic strains used.

The evolution of these strains and the subsequent loss of certain genes, are creating weaker immune reactions, note the scientists.

French scientists originally developed the BCG vaccine, which has been running for the last 90 years, in 1908. They managed to make a strain of tuberculosis (TB) less potent by growing it in a glycerin-potato mixture.

This meant when used in a vaccine it would produce an immune response without causing the actual disease. Once they found it was safe, they began to distribute the vaccine around the world.

Since the 1960s, there have been reports of the declining efficacy of the BCG vaccine.

A study in babies published in 2006 found that the early Japan strain prompted a stronger immune reaction than three newer strains that are used in 66% of modern immunizations.

Study leader, Dr Roland Brosch, senior researcher at the Institut says: "The earlier strains have undergone fewer genetic changes.

"The later strains were selected because they had the least side effects but maybe the efficiency has become less and less."

Brosch advises more research into the matter coupled with methods of making the present vaccines more effective.

The Health Protection Agency of U.K welcomed the research and added that EU sponsored clinical trials were in the process of re-evaluating older strains.

The agency was quoted : "A number of other approaches are being actively investigated to improve the protection provided by the current BCG vaccine strains.

"Clinical trials over the next five to seven years will provide evidence as to which approach will be most successful."

TB rates have skyrocketed since the 1980s in places such as the former Soviet Union and sub-Saharan Africa.

Dr. Marcel Behr of Montreal's McGill University says the new study is "a clarion call to create a better vaccine." He said one option is to recreate the original BCG genome and "reconstruct something more closely resembling the original bacterium."

The World Health Organization estimates 1.7 million people died from TB in 2004.

Related medicine news :

1. Intro of Pneumococcal Vaccines: Experts Urge Commitment From Industry
2. Drug Found To Bring Relief For Individuals With Early Parkinson’
3. Improving Lighting Could Bring About A Change In Alzheimers Patients
4. Researchers Bring New Insight To Asthma And SABA Fills
5. Stardust Brings Interstellar Dust
6. Free HIV Tests Brings Crowd to the Testing Centers
7. East Asian Immigrants Bring Hepatitis to New York
8. Medico’s Return to Work Bringing Respite to Patient
9. Singapore Manufacturer to Bring Ethnic Foods to the World
10. Revamping Of Healthcare System Required To Bring Down Preventable Medical Errors
11. Anesthesia Drug To Bring Solace To The Depressed
Post Your Comments:

(Date:11/25/2015)... ... November 25, 2015 , ... On November 25, 2015, officials of ... Narconon network, announced the release of a new cutting edge recovery program that has ... been working with drug- and alcohol-addicted individuals with the purpose to free addicts from ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... On November ... of Tri Lite’s personal heating products business. Cozy Products explains what this ... heaters that fit in well with the Cozy Products business model: to sell personal ...
(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a new Android ... The new app features a more intuitive SleepScore™ that rates sleep quality on a ... The SleepScore is created by a proprietary algorithm. Beddit analyzes the data to provide ...
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I saw a passenger ... thought there had to be a convenient and comfortable way to protect them from ... disabled individuals to safely travel during cold or inclement weather. In doing so, it ...
(Date:11/25/2015)... ... November 25, 2015 , ... In honor of Pulmonary Hypertension ... and groups responsible for advancing care for pulmonary hypertension (PH) patients and helping ... public, will receive special recognition throughout 2016 as part of PHA’s 25th anniversary ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... -- WuXi PharmaTech (Cayman) Inc. ("WuXi" or the "Company") ... and technology platform company serving the pharmaceutical, biotechnology, and ... and the United States ... of shareholders held today, the Company,s shareholders voted in ... previously announced agreement and plan of merger (the "Merger ...
(Date:11/24/2015)... Calif. , Nov. 24, 2015 /PRNewswire/ ... leader in non-invasive genetic testing and the ... that it will present at the 27 ... York on Wednesday, December 2, 2015 at 1:00 p.m. ET.  Matthew Rabinowitz, ... Company,s financial results, business activities and financial ...
(Date:11/24/2015)... 2015  In the pharmaceutical industry, companies want to ... quickly uncover new insights, tactics and strategies that will ... --> However, organizations often find it is ... ensure that all rules and regulations are met to ... barrier to efficiently launching market research projects is the ...
Breaking Medicine Technology: